A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Clinical trial NCT04880876 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04880876
- Sponsor
- AbbVie
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-13
- Primary completion
- 2032-12-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.